MRP of 3 anti-cancer drugs to come down due to exemption from custom duty and reduction in GST Read more
Evive, Acrotech get FDA nod for Ryzneuta (Efbemalenograstim alfa Injection) for chemo-induced neutropenia Read more
Sathgen Therapeutics announces completion of first cohort in phase 1 clinical trial with anti-cancer drug Read more